Screening

Myths and fears about cancer screening may be keeping some of your patients from important tests. Always ask about misconceptions, and then offer the facts.

ACP 2025: Lung cancer is rising among nonsmokers, especially women. Kim Sandler, MD, discusses future screening challenges, research insights, and the need to expand screening eligibility.

Your daily dose of the clinical news you may have missed.

ACP 2025: Kim Sandler, MD, outlines key strategies to boost lung cancer screening uptake in primary care.

ACP 2025: Kim Sandler, MD, explains how primary care physicians can use shared decision-making to guide patients through lung cancer screening, emphasizing risk, benefit, follow-up, and smoking cessation.

ACP 2025: Kim Sandler, MD, sat down with Patient Care to discuss the benefits of lung cancer screening, citing a 20% reduction in lung cancer mortality with annual screenings.

ACP 2025: Kim Sandler, MD, discussed the latest screening guidelines, real-world challenges in implementation, and the essential role of shared decision-making.

Your daily dose of the clinical news you may have missed.

The model identified BMI, tobacco use, and family history of CRC as the strongest predictors for advanced neoplasia in young adults.

The number of lung cancer deaths averted represents more than 51% of the expected reduction in total cancer deaths, researchers reported.

Adding a deadline to a mailed invitation for FIT colorectal cancer screening resulted in improved return rates, according to new research.

The greatest risk for developing cancer faces residents of South Dakota, where radon levels are the nation's highest, and ranks for alcohol consumption and obesity are poor.

CROI 2025: Researchers reported that a universal syphilis screening program identified more cases than programs targeting specific patient populations.

New AGA guidelines conclude that it is not clear whether computer-aided detection systems for colonoscopy should be recommended for routine widespread use.

CROI 2025: Increased HPV vaccine coverage could reduce HIV cases by thousands, according to a new study.

Cervical cancer screening rates remained below prepandemic levels, while rates for breast and colorectal cancers rebounded from pandemic declines.

New evidence-based guidance for bowel prep considers patient preference and history and updates timing of prep regimen, dietary restrictions, and follow-up recommendations.

A family medicine specialist who works with cancer survivorship highlights findings of a study that illustrate how effective screening is and how treatment has changed.

William Grady, MD, coauthor of the ECLIPSE trial, discusses how the Shield cfDNA blood-based test compares to traditional CRC screening methods.

Results from the MASAI clinical trial also showed that AI-assisted screening reduced screen-reading workload without increasing the rate of false-positives.

World Cancer Day 2025 urges focus on the unique personal journey underlying every cancer diagnosis; individual recommendations for regular screening is where that can start.

William Grady, MD, coauthor of the ECLIPSE study, discusses the use of non-invasive cfDNA blood-based tests for CRC screening in older adults.

William Grady, MD, highlights ongoing efforts to improve test sensitivity and developments of new blood-based tests for early detection of CRC.